Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canadian Hidradenitis Suppurativa Foundation (CHSF) is a non-profit organization dedicated to improving the lives of Canadians living with Hidradenitis Suppurativa (HS). Founded in 2014, the foundation focuses on three main pillars: education, advocacy, and research. CHSF provides essential resources for patients and healthcare providers, including clinical practice guidelines and educational programs like the HS Academy for dermatology residents. The organization co-hosts the annual Symposium on Hidradenitis Suppurativa Advances (SHSA), the premier assembly for HS researchers in North America. Through its initiatives, CHSF aims to reduce the time to diagnosis and optimize the management of this chronic inflammatory skin disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Hidradenitis Suppurativa Foundation.